Tango Therapeutics Inc (TNGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 09-2020 | |
| Assets | ||
| Current Assets | ||
| Cash & Cash Equivalents | N/A | 1,552 |
| TOTAL | $N/A | $1,622 |
| Non-Current Assets | ||
| Investments And Advances | 0 | 166,762 |
| TOTAL | $N/A | $166,762 |
| Total Assets | $N/A | $168,384 |
| Liabilities | ||
| Current Liabilities | ||
| Accounts payable and accrued liabilities | 0 | 5 |
| Accrued Expenses | N/A | 74 |
| TOTAL | $N/A | $115 |
| Non-Current Liabilities | ||
| Other Non-Current Liabilities | 0 | 157,432 |
| TOTAL | $N/A | $163,269 |
| Total Liabilities | $N/A | $163,384 |
| Shareholders' Equity | ||
| Shares Outstanding, K | 21,377 | 21,377 |
| Common Shares | N/A | 1 |
| Retained earnings | N/A | -53 |
| TOTAL | $N/A | $5,000 |
| Total Liabilities And Equity | $0 | $168,384 |